Desferrioxamine-related ocular toxicity: A case report

Indian Journal of Ophthalmology

Volumn 60, Issue 4, 2012, Pages 315-317

  Simon, Sumu ^a   Athanasiov, Paul A ^a   Jain, Rajeev ^a   Raymond, Grant ^a   Gilhotra, Jagjit S ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Desferrioxamine; ocular toxicity; optic neuropathy; pigmentary retinopathy

Indexed keywords

DEFEROXAMINE; SIDEROPHORE;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; ELECTRORETINOGRAPHY; EVOKED VISUAL RESPONSE; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; OPTIC NERVE DISEASE; RETINA DISEASE;

ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; DEFEROXAMINE; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRORETINOGRAPHY; EVOKED POTENTIALS, VISUAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; HUMANS; OPTIC NERVE DISEASES; RETINAL DISEASES; SIDEROPHORES;

EID: 84864440236     PISSN: 03014738     EISSN: 19983689     Source Type: Journal    
DOI: 10.4103/0301-4738.98714     Document Type: Article

References (9)

1. Weatherall DJ, Clegg JB. The Thalassamia Syndromes. 4th ed. Oxford: Blackwell Sciences Ltd; 2001.
2. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997;89:739-61.
3. Arora A, Wren S, Gregory Evans K. Desferrioxamine related maculopathy: A case report. Am J Hematol 2004;76:386-8.
4. Davies SC, Marcus RE, Hungerford JL, Miller MH, Arden GB, Huehns ER. Ocular toxicity of high-dose intravenous desferrioxamine. Lancet 1983;2:181-4.
5. Haimovici R, D'Amico DJ, Gragoudas ES, Sokol S. The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology 2002;109:164-71.
6. Davis BA, Porter JB. Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia. Blood 2000;95:1229-36.
7. Porter JB. A risk-benefit assessment of iron-chelation therapy. Drug Saf 1997;17:407-21.
8. Lai TY, Lee GK, Chan WM, Lam DS. Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion. Br J Ophthalmol 2006;90:243-4.
9. Porter JB, Jaswon MS, Huehns ER, East CA, Hazell JW. Desferrioxamine ototoxicity: Evaluation of risk factors in thalassaemic patients and guidelines for safe dosage. Br J Haematol 1989;73:403-9.